CN1580272A - Method for producing somatic powder containing lovastatin by liquid submerged fermentation - Google Patents
Method for producing somatic powder containing lovastatin by liquid submerged fermentation Download PDFInfo
- Publication number
- CN1580272A CN1580272A CN 200410038293 CN200410038293A CN1580272A CN 1580272 A CN1580272 A CN 1580272A CN 200410038293 CN200410038293 CN 200410038293 CN 200410038293 A CN200410038293 A CN 200410038293A CN 1580272 A CN1580272 A CN 1580272A
- Authority
- CN
- China
- Prior art keywords
- lovastatin
- seed
- monascus
- preparation
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention can be used to get farlutating thallus powder by deep submerged fermentation in liquid. Whicn can be used to make all kinds of food or drug for depress blood fat. The whole manufactory process of monascus thalli powder follows five steps. 1, pure bred on bevel. 2, rocking seed in two level. 3, culture in seed tank. 4, fermentation and culture in fermenter tank..5, get monascus thalli powder containing 1.2% farlutating after abrading, isotroping and atomized drying the monascus thalli. The craft is easy and parameter can be controlled. The whole production is airproof so it is different to be polluted. The outcome is pure and its quality is good. Besides, the labour intensity is low.
Description
Technical field:
The present invention relates to a kind of preparation method of bacterial classification powder, relate in particular to a kind of liquid submerged fermentation method and produce the method that contains 1.2% lovastatin thalline powder.
Background technology:
Monascus is to be used for producing the main bacteria seed of wine of rice fermented with red yeast and monascorubin to wait the food color of works to its fermented product red colouring agent for food, also used as a Chinese medicine, the existing loading of the application of food antiseptic and drug medical aspect at the history of the existing more than one thousand years of China " Compendium of Materia Medica) ", " animal doctor this chapter) ", " Tian Gong Kai Wu) ".After Japan rattan chapter professor far away isolated cholesterol synthesis inhibitor from red monascus in 1979, the function of monascus and application are subjected to domestic and international extensive concern, obtained comprehensive deep research, the existing how tame food company of Japan drop into product that a large amount of manpower and materials carry out the listing of health red rice development of food can reducing blood-fat be popular and for inventor China of red colouring agent for food, also used as a Chinese medicine not show song protective foods take advantage.The functional Monascus product has only several places such as Fujian, Zhejiang, Hebei that production is arranged in China, the red colouring agent for food, also used as a Chinese medicine made by the monascus fermentation such as the zhibituo in Pekinese's Xuezhikang, Chengdu also occupies certain market as blood lipid-lowering medicine in addition.But generally speaking, the shared market share of functional Monascus product is also little, the lovastatin that monascus ruber produces is very big and be free from side effects to reducing blood lipid, and the functional Monascus that China produces now is still with the ancient method of koji tray or aerated koji making, labour intensity is big, easy pollution of products, it is low that product contains lovastatin.
Summary of the invention:
Effects such as technical problem to be solved by this invention provides a kind of liquid submerged fermentation method for preparing and produces the method that contains 1.2% lovastatin thalline powder, and it is simple that this method has production technique, and the health-care effect of product purity and product is obvious.
The present invention selects tens strain monascus rubers through separating, screening, and obtains the higher red monascus of strain product lovastatin and passes through ultraviolet ray and cobalt 60 (Co again
60) shine repeatedly and carry out mutagenesis.Obtain the mutagenic strain T-180 that a plant height produces the red monascus of lovastatin.
The applicant is deposited in China Committee for Culture Collection of Microorganisms common micro-organisms center on May 19th, 2004, and it abbreviates CGMCC as, and deposit number is 1148.The address of China Committee for Culture Collection of Microorganisms's common micro-organisms center (it abbreviates CGMCC as) is: No. 13, North No.1 Row, Zhongguancun, Haidian District, Beijing City, Institute of Microorganism, Academia Sinica (100080).
The mutagenic strain T-180 classification called after of the red monascus of this high yield lovastatin: belong to the red monascus bacterial classification.
The content that the monascus thalline powder that the present invention utilizes this this bacterium to make contains lovastatin is 1.2%, the content that is higher than the functional red yeast rice lovastatin of present China far away, and I am the production of adopting the automatic controlled liq submerged fermentation of a complete set of sealing, the purity height, produce and stablize, be difficult for the modern production technology of polluting.
The present invention adopts a plant height of my mutagenesis to produce the red monascus mutagenic strain T-180 of lovastatin through slant culture one-level shake-flask culture, the secondary shake-flask culture, again through seed tank culture, arrive fermentor cultivation again through defibrination, the homogeneous spraying drying powder-forming, promptly contain 1.2% lovastatin monascus thalline powder and be pink, with medicine and the food of making various reducing blood-fat.
The production of monascus thalline powder of the present invention is divided into bacterial classification production and fermentation two portions:
One, bacterial classification production:
1, the purebred preparation in inclined-plane:
1., the preparation of slant medium: 100 milliliters of worts, agar 3 grams are transferred PH4.2-4.5, heating agar dissolves fully that to put into the inclined-plane after the sterilization in 1 kilogram/30 minutes of the good tampon of back packing test tube plug stand-by;
2., the purebred preparation in inclined-plane: will make slant medium under aseptic condition, insert red monascus purebred 32 ℃ ± 1 cultivate 10-15 days stand-by.
2, the preparation of shake-flask seed
1., the preparation of one-level shake-flask seed
The preparation of a, seed culture medium: rice meal 5%, peptone 1.5%, corn steep liquor 1%, maltose 1%, amino acid 0.1%, potassium primary phosphate 0.25%, sal epsom 0.1%, divide after the abundant gelatinization of PH4.2-5 rice meal to install in 500 milliliters of triangular flasks, 80 milliliters of liquid amounts, the sterilization postcooling was stand-by in 1 kilogram/30 minutes.
The preparation of b, one-level shake-flask seed: will prepare 500 milliliters (the triangular flask nutrient solution inserts purebred under aseptic condition, filled in tampon and be placed on 32 ℃ ± 1 constant temperature shaking table, 300 rev/mins of revolutions, cultivate 24 hours stand-by.
2., the preparation of secondary shake-flask seed
The preparation of a, seed culture medium: rice meal 5%, peptone 1.5%, corn steep liquor 1%, amino acid 0.1%, maltose 1%, potassium primary phosphate 0.25%, sal epsom 0.1%, be divided in 2000 milliliters of bottles after the abundant gelatinization of the big powder rice of PH4.2-5, liquid amount is 300 milliliters, and the sterilization postcooling was stand-by in 1 kilogram/30 minutes.
The preparation of b, secondary shake-flask seed will have been cultivated one-level kind liquid and inserted in the substratum of 2000 milliliters of triangular flasks by 6% inoculum size under aseptic condition, filled in tampon, be placed on 32 ℃ ± 1 constant temperature shaking table and cultivate, 300 rev/mins of revolutions, cultivate 24 hours stand-by.
C, will cultivate the secondary shake-flask seed and under aseptic condition, pour in the inoculation bottle stand-by.
Two, fermentation:
1, the cultivation of 50 liters of seeding tanks
1., seed culture medium rice meal 5%, maltose 1%, corn steep liquor 1%, amino acid 0.1%, peptone 1.5%, phosphoric acid ammonia dipotassium 0.2%, sal epsom 0.1% is adjusted pH value 4.2-5;
2., liquid amount 70%, control Intake Quantity be 35 kilograms of substratum, sterilization 1 kilogram/30 minutes;
3., 45 ℃ of inoculation temps, will inoculate by 6% inoculum size, and with pressure difference method access shake-flask seed;
4., tank pressure 0.1MPA stirs 380 rev/mins of revolutions, ventilating ratio is 1: 0.7;
5., culture temperature 32 ℃ ± 1;
6., incubation time is 24 hours.
2,500 liters of cultivations of jar of turning sour;
1., the substratum rice meal 7% that turns sour, maltose 1.5%, corn steep liquor 1.5%, peptone 2%, potassium primary phosphate 0.2%, sal epsom 0.1%, PH4.2-5, sterilization 1 kilogram/30 minutes;
2., liquid amount 70% is 350 kilograms, 45 ℃ of inoculation temps;
3., inoculum size by 6% the inoculation, the pressure difference method inserts fermentor tank with cultured seed;
4., 32 ℃ of culture temperature, air flow is 1: 0.7, control PH5.2-5.5, tank pressure 0.1MPA;
5., incubation time (168 hours) stirring in 7 days revolution is 320 rev/mins;
3, defibrination:
With cultured fermented liquid colloidal mill, grinding 2 fineness is 120 orders.
4, homogeneous:
To grind good monascus fermented liquid through the clarifixator homogeneous, homogeneous, fineness 300 orders behind the homogeneous.
5, drying:
130 ℃ of spray-drier inlet temperatures of the monascus fermented liquid that homogeneous is good, 62 ℃ of temperature outs, spraying drying powder-forming promptly obtains containing lovastatin 1.2% monascus thalline powder.
The manufacture method of lovastatin-containing red koji mold body powder of the present invention is that the production of present China contains the exclusive production method of lovastatin red colouring agent for food, also used as a Chinese medicine, produce red colouring agent for food, also used as a Chinese medicine thalline powder and contain lovastatin 1.2%, this method production contains lovastatin monascus body powder and all oneself controls sealing production, do not pollute, impurity is few, easy to control, labour intensity is little, lovastatin content height.The protective foods of the reducing blood-fat of making is effective.
Embodiment:
The specific implementation method of the production of monascus thalline powder provided by the invention is divided into five parts:
1, the purebred cultivation in monascus inclined-plane.
2, the cultivation of I and II shake-flask seed.
3, the cultivation of monascus seeding tank.
4, the cultivation of monascus fermentation;
5, defibrination, even matter are finished product to spraying drying powder-forming---contain the monascus body powder of 1.2% lovastatin.
Below we describe the present invention in detail by specific measures for implementation:
1, the purebred cultivation in inclined-plane:
1. the preparation of slant medium:
With 100 milliliters of worts, agar 3 gram mixes, and pH value is aligned 3.5, and heating fully dissolves agar to put into the inclined-plane after the sterilization in 1 kilogram/30 minutes of the good tampon of back packing test tube plug stand-by;
2. the purebred preparation in inclined-plane:
With the above-mentioned slant medium that makes under aseptic condition, insert red monascus purebred 32 ℃ ± 1 cultivate 15 days stand-by.
2, the preparation of shake-flask seed:
1. the preparation of one-level shake-flask seed
The preparation of a, seed culture medium:
Prepare this seed culture medium according to following composition and ratio and method:
Rice meal 5%, peptone 1.5%, corn steep liquor 1%, maltose 1%, amino acid 0.1%, potassium primary phosphate 0.25%, sal epsom 0.1% is after the abundant gelatinization of the rice meal of pH value 4.5, divide to install in 500 milliliters of triangular flasks, liquid amount is 80 milliliters, and the sterilization postcooling was stand-by in 1 kilogram/30 minutes;
The preparation of b, one-level shake-flask seed:
In 500 milliliters of triangular flasks, aseptic condition inserts purebred down with the nutrient solution for preparing, filled in tampon to be placed on 32 ℃ ± 1 constant temperature shaking table, 300 rev/mins of revolutions, cultivate 24 hours stand-by.
2., the preparation of secondary shake-flask seed:
The preparation of a, seed culture medium:
Prepare this seed culture medium according to following composition and ratio and method:
Rice meal 5%, peptone 1.5%, corn steep liquor 1%, amino acid 0.1%, maltose 1%, potassium primary phosphate 0.25%, sal epsom 0.1%, be divided in 2000 milliliters of triangular flasks after the abundant gelatinization of big powder rice with pH value 4.5, liquid amount is 300 milliliters, and the sterilization postcooling was stand-by in 1 kilogram/30 minutes;
The preparation of b, secondary shake-flask seed:
Under aseptic condition, will cultivate one-level kind liquid and insert in the substratum of 2000 milliliters of triangular flasks, fill in tampon, and be placed on 32 ℃ ± 1 constant temperature shaking table and cultivate by 6% inoculum size, 300 rev/mins of revolutions, cultivate 24 hours stand-by;
C, will cultivate the secondary shake-flask seed and under aseptic condition, pour in the inoculation bottle, stand-by;
Fermenting process:
1, the cultivation of 50 liters of seeding tanks:
1., the prescription of seed culture medium:
Rice meal 5%, maltose 1%, corn steep liquor 1%, amino acid 0.1%, peptone 1.5%, phosphoric acid ammonia dipotassium 0.2%, sal epsom 0.1% is adjusted into 4.5 with pH value;
Concrete working method is:
2., liquid amount 70%, the 35 kilograms of substratum of packing into; Sterilization 1 kilogram/30 minutes;
3., inoculation temp is controlled at about 45 ℃, inoculate by 6% inoculum size, and insert shake-flask seed with conventional pressure difference method;
4., tank pressure is controlled at about 0.1MPA, stirs simultaneously, stirs 380 rev/mins of revolutions, ventilating ratio is 1: 0.7;
5., culture temperature is controlled at about 32 ℃;
6., incubation time is 24 hours;
2,500 liters of cultivations of jar of turning sour:
1., the turn sour prescription of substratum is:
Rice meal 7%, maltose 1.5%, corn steep liquor 1.5%, peptone 2%, potassium primary phosphate 0.2%, sal epsom 0.1% is adjusted pH value 4.5, sterilization 1 kilogram/30 minutes;
2., liquid amount 70%, approximately be controlled at 350 kilograms, 45 ℃ of inoculation temps;
3., the pressure difference method inserts fermentor tank with cultured seed, the seed of seed tank culture is inoculated in the ratio of inoculum size 6%;
4., 32 ℃ of culture temperature, air flow is 1: 0.7, about control PH5.2-5.5, tank pressure is controlled at about 0.1MPA;
5., incubation time 7 days (168 hours), stirring revolution is 320 rev/mins.
3, defibrination: with cultured fermented liquid colloidal mill, grind 2 times, fineness is 120 orders.
4, homogeneous: will grind good monascus fermented liquid through the clarifixator homogeneous, homogeneous, fineness 300 orders behind the homogeneous.
5, drying: 130 ℃ of spray-drier inlet temperatures of the monascus fermented liquid that homogeneous is good, 62 ℃ of temperature outs, spraying drying powder-forming promptly obtains containing lovastatin 1.2% monascus thalline powder.
Claims (7)
1, a kind of liquid submerged fermentation method is produced the method that contains 1.2% lovastatin thalline powder, it is characterized in that: this method is to adopt a plant height to produce the Monascus color aspergillus mutagenic strain T-180 of lovastatin, contains lovastatin 1.2% monascus thalline powder through the purebred cultivation of bacterial classification, shake-flask seed cultivation, seed tank culture, fermentation culture, defibrination homogeneous, spray drying process preparation.
2, production as claimed in claim 1 contains the method for 1.2% lovastatin thalline powder, and it is characterized in that: the method for described spawn culture is:
1, the purebred preparation in inclined-plane:
1., the preparation of slant medium:
100 milliliters of worts, agar 3 grams are transferred PH4.2-4.5, and heating agar fully dissolves back packing test tube, has filled in tampon, and it is stand-by to put into the inclined-plane after the sterilization in 1 kilogram/30 minutes;
2., the purebred cultivation of bacterial classification: will make slant medium under aseptic condition, it is purebred to insert Monascus color aspergillus, cultivates 10-15 days 32 ℃ ± 1, stand-by.
3, production as claimed in claim 1 contains the method for 1.2% lovastatin thalline powder, it is characterized in that: described shake-flask seed cultured method is:
1., the preparation of one-level shake-flask seed;
The preparation of a, seed culture medium:
Rice meal 5%, peptone 1.5%, corn steep liquor 1%, maltose 1%, amino acid 0.1%, potassium primary phosphate 0.25%, sal epsom 0.1%, divide after the abundant gelatinization of PH4.2-5 rice meal to install in 500 ml containers, 80 milliliters of liquid amounts, the sterilization postcooling was stand-by in 1 kilogram/30 minutes;
The preparation of b, one-level shake-flask seed: 500 milliliters of nutrient solutions that will prepare insert purebred under aseptic condition, the constant temperature shaking table 32 ℃ ± 1,300 rev/mins of revolutions, cultivate 24 hours stand-by;
2., the preparation of secondary shake-flask seed;
The preparation of a, seed culture medium: rice meal 5%, peptone 1.5%, corn steep liquor 1%, amino acid 0.1%, maltose 1%, potassium primary phosphate 0.25%, sal epsom 0.1%, be divided in 2000 ml containers after the abundant gelatinization of the big powder rice of PH4.2-5, liquid amount is 300 milliliters, and the sterilization postcooling was stand-by in 1 kilogram/30 minutes;
The preparation of b, secondary shake-flask seed will have been cultivated under aseptic condition in one-level kind liquid inserts 2000 milliliters by 6% inoculum size the substratum, and the constant temperature shaking table 32 ℃ ± 1 is cultivated, 300 rev/mins of revolutions, cultivate 24 hours stand-by;
C, will cultivate the secondary shake-flask seed and under aseptic condition, inoculate stand-by.
4, production as claimed in claim 1 contains the method for 1.2% lovastatin thalline powder, and it is characterized in that: the method for described seed tank culture is:
1, the cultivation of 50 liters of seeding tanks;
1., seed culture medium rice meal 5%, maltose 1%, corn steep liquor 1%, amino acid 0.1%, peptone 1.5%, phosphoric acid ammonia dipotassium 0.2%, sal epsom 0.1%, PH4.2-5;
2., liquid amount 70%, the 35 kilograms of substratum sterilizations 1 kilogram/30 minutes of packing into;
3., 45 ℃ of inoculation temps, will inoculate by 6% inoculum size, and with pressure difference method access shake-flask seed;
4., tank pressure 0.1MPA stirs 380 rev/mins of revolutions, ventilating ratio is 1: 0.7;
5., culture temperature is 32 ± 1 ℃;
6., incubation time is 24 hours;
2,50 liters of cultivations of jar of turning sour;
The prescription of fermented liquid: PH4.2-4.5 rice meal 7%, malt meal 1.5%, corn steep liquor 1.5%, peptone 2%, potassium primary phosphate 0.2%, sal epsom 0.1%;
(1), its cultural method is:
1., liquid amount 70%, sterilization 1 kilogram/30 minutes;
2., the pressure difference method inserts the secondary shake-flask seed inoculum size 6%;
3., inoculation temp is 45 ℃;
4., culture temperature is 35 ± 1 ℃;
5., ventilation is 1: 0.6;
6., the electric motor revolution is 380 rev/mins;
7., tank pressure 0.1MPA;
8., incubation time is 24 hours;
(2), the culture condition of fermentor tank:
1., liquid amount 70%;
2., inoculation temp is 45 ℃;
3., the pressure difference method inserts inoculum size 6% with the seed of seeding tank;
4., ventilation is 1: 0.6;
5., culture temperature 35 ℃ ± 1;
6., control PH5.2-5.5;
7., the electric motor revolution is 320 rev/mins;
8., tank pressure 0.1MPA;
9., incubation time is 168 hours;
5, production as claimed in claim 1 contains the method for 1.2% lovastatin thalline powder, it is characterized in that:
The method of described defibrination is: with cultured fermented liquid colloidal mill, grinding 2 fineness is 120 orders.
6, production as claimed in claim 1 contains the method for 1.2% lovastatin thalline powder, and it is characterized in that: the method for described homogeneous is: will grind good monascus fermented liquid through the clarifixator homogeneous, homogeneous, fineness 300 orders behind the homogeneous.
7, production as claimed in claim 1 contains the method for 1.2% lovastatin thalline powder, it is characterized in that: described exsiccant method is: 130 ℃ of spray-drier inlet temperatures of the monascus fermented liquid that homogeneous is good, 62 ℃ of temperature outs, spraying drying powder-forming promptly contains lovastatin 1.2% monascus thalline powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410038293 CN1242068C (en) | 2004-05-21 | 2004-05-21 | Method for producing somatic powder containing lovastatin by liquid submerged fermentation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410038293 CN1242068C (en) | 2004-05-21 | 2004-05-21 | Method for producing somatic powder containing lovastatin by liquid submerged fermentation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1580272A true CN1580272A (en) | 2005-02-16 |
| CN1242068C CN1242068C (en) | 2006-02-15 |
Family
ID=34582128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410038293 Expired - Fee Related CN1242068C (en) | 2004-05-21 | 2004-05-21 | Method for producing somatic powder containing lovastatin by liquid submerged fermentation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1242068C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102533894A (en) * | 2011-12-22 | 2012-07-04 | 中山大学 | Method for maintaining stable content of Monacolin K and its acid structure in monascus |
| CN102559795A (en) * | 2010-12-20 | 2012-07-11 | 北大方正集团有限公司 | Method for producing lovastatin by fermentation and fermentation medium used by same |
| CN105054021A (en) * | 2015-08-04 | 2015-11-18 | 江苏大学 | Monascus purpureus transformed corn bran fermentation liquid preparation method and application thereof |
| CN105695527A (en) * | 2016-04-27 | 2016-06-22 | 山东鲁抗医药股份有限公司 | Culture medium for lovastatin fermentation and supplementing method for fermentation process |
| CN108865897A (en) * | 2018-06-29 | 2018-11-23 | 夏放军 | A kind of high yield type monascus strain culture medium and preparation method thereof |
| CN110592155A (en) * | 2019-09-12 | 2019-12-20 | 北京工商大学 | Application of arginine in improving monacolin K production by monascus purpureus |
-
2004
- 2004-05-21 CN CN 200410038293 patent/CN1242068C/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102559795A (en) * | 2010-12-20 | 2012-07-11 | 北大方正集团有限公司 | Method for producing lovastatin by fermentation and fermentation medium used by same |
| CN102533894A (en) * | 2011-12-22 | 2012-07-04 | 中山大学 | Method for maintaining stable content of Monacolin K and its acid structure in monascus |
| CN105054021A (en) * | 2015-08-04 | 2015-11-18 | 江苏大学 | Monascus purpureus transformed corn bran fermentation liquid preparation method and application thereof |
| CN105695527A (en) * | 2016-04-27 | 2016-06-22 | 山东鲁抗医药股份有限公司 | Culture medium for lovastatin fermentation and supplementing method for fermentation process |
| CN108865897A (en) * | 2018-06-29 | 2018-11-23 | 夏放军 | A kind of high yield type monascus strain culture medium and preparation method thereof |
| CN110592155A (en) * | 2019-09-12 | 2019-12-20 | 北京工商大学 | Application of arginine in improving monacolin K production by monascus purpureus |
| CN110592155B (en) * | 2019-09-12 | 2021-07-06 | 北京工商大学 | Application of arginine in improving monacolin K production by monascus purpureus |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1242068C (en) | 2006-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1273004C (en) | Method for producing hedgehog fungus and special culture medium thereof | |
| CN101063086A (en) | Preparation method for special mother seed of edible mushroom liquid bacterial | |
| CN1141375C (en) | Se-enriched high-biomass yeast and its preparing process | |
| CN1365603A (en) | Method of culturing mycellium by using grain, its product use for culturing product | |
| CN1244266C (en) | Method for producing edible fungus liquid strain | |
| CN101513161A (en) | Formula for culture medium of cordyceps militaris liquid strains and method for culturing same | |
| CN101045910A (en) | Preparation of propionic acid and co-production of vitamin B by using propionibacterium freudenre NX-412Method (2) | |
| CN102154168B (en) | Abamectin producing bacterium and preparation method thereof | |
| CN1232632C (en) | New strain APC-20 of Paecilomyces cicadae and fementation process for artificial culture | |
| CN102113629A (en) | Method for preparing dairy cow feed by microbial fermentation | |
| CN114468121B (en) | Method for fermenting food industry leftovers by using fermentation agent containing Bacillus belgii | |
| CN1242068C (en) | Method for producing somatic powder containing lovastatin by liquid submerged fermentation | |
| CN1740303A (en) | Production process of rich fragrance wine | |
| CN1899080A (en) | Active protein feed and its preparing method | |
| CN1908178A (en) | Method of low cost preparing gamma-polyglutamic acid utilizing farm and side line products solid fermentation | |
| CN1306020C (en) | Polyporus frondosus oral liquor and its prodn. method | |
| CN101210224A (en) | Liquid culture medium for culturing mematophagous fungi and method for preparing chlamydospore of the same | |
| CN100513549C (en) | Liquid mushroom producing method and fermenting set | |
| CN1884560A (en) | Ferment method for producing 2.3-butanediol | |
| CN101045905A (en) | Domesticated and selectively bred autoflocculating yeast mutant plant and its application | |
| CN1269395C (en) | Preparation method of special mother strain for producing edible fungus liquid strain | |
| KR100204983B1 (en) | The method of culturing liquid starter of basidomycetis and the apparatus for culturing it and the starter | |
| CN106035985A (en) | Method for producing single cell proteins by using processed waste from mixed bacteria liquid fermentation of yellow wine | |
| CN109924487A (en) | A kind of preparation method of selenium-enriched anka | |
| CN1498865A (en) | Micro ecological agent for supporting water in fishing use and its prepn. method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |